ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 21 filers reported holding ARCA BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $14,000 | +16.7% | 10,452 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | -52.0% | 10,452 | 0.0% | 0.00% | – |
Q2 2017 | $25,000 | -7.4% | 10,452 | 0.0% | 0.00% | – |
Q1 2017 | $27,000 | -10.0% | 10,452 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $30,000 | 0.0% | 10,452 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $30,000 | 0.0% | 10,452 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $30,000 | – | 10,452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aveo Capital Partners, LLC | 93,258 | $35,000 | 0.02% |
Tekla Capital Management LLC | 811,227 | $303,000 | 0.01% |
BANK OF AMERICA CORP /DE/ | 576 | $0 | 0.00% |
NORTHERN TRUST CORP | 13,986 | $5,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 48,679 | $18,000 | 0.00% |
MORGAN STANLEY | 2,000 | $1,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 219,236 | $82,000 | 0.00% |
BlackRock Inc. | 865 | $0 | 0.00% |
Citadel Advisors | 81,938 | $31,000 | 0.00% |